<ul>S</ul>ystemic hydrocortisone <ul>to </ul><ul>p</ul>revent <ul>b</ul>roncho<ul>p</ul>ulmonary <ul>d</ul>ysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial

• Main Authors: Onland Wes (Author), Offringa Martin (Author), Cools Filip (Author), De Jaegere Anne P (Author), Rademaker Karin (Author), Blom Henry (Author), Cavatorta Eric (Author), Debeer Anne (Author), Dijk Peter H (Author), van Heijst Arno F (Author), Kramer Boris W (Author), Kroon Andre A (Author), Mohns Thilo (Author), van Straaten Henrica L (Author), te Pas Arjan B (Author), Theyskens Claire (Author), van Weissenbruch Mirjam M (Author), van Kaam Anton H (Author)
• Format: Book
• Published: BMC, 2011-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Randomized controlled trials have shown that treatment of chronically ventilated preterm infants after the first week of life with dexamethasone reduces the incidence of the combined outcome death or bronchopulmonary dysplasia (BPD)....